KCNQ1 autoantibodies
Arginase as a potential target in the treatment of cardiovascular disease
Salusin-β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats
Osteopontin deficiency dampens the pro-atherogenic effect of uraemia
TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension
An SRF/miR-1 axis regulates NCX1 and Annexin A5 protein levels in the normal and failing heart
Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin
Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes
Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis
Enhanced cell-volume regulation in cyclosporin A cardioprotection
Cardioprotection by the TSPO ligand 4′-chlorodiazepam is associated with inhibition of mitochondrial accumulation of cholesterol at reperfusion
Prolonged vasoconstriction of resistance arteries involves vascular smooth muscle actin polymerization leading to inward remodelling
Hypoxia-induced autophagy in endothelial cells
Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles
miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat
Tyrosine 284 phosphorylation is required for ClC-3 chloride channel activation in vascular smooth muscle cells
AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids
A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation
Anti-KCNQ1 K+ channel autoantibodies increase I Ks current and are associated with QT interval shortening in dilated cardiomyopathy
Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis
Aims and Scope
Cover Page
Editorial Board
Contents Page